January 17, 2013
From: Laura Clark
Director of Media Relations
ULM pharmacy professor invited to share his cancer research expertise
Dr. Girish Shah, basic pharmaceutical sciences professor at the University of Louisiana at Monroe, was asked to present and join the organizing committee for the International Conference on Genetic Syndromes and Gene Therapy.
The conference was recently held in San Antonio, Texas and attended by scientists from several countries, including Europe, Korea and Singapore.
Shah presented, “Adenoassociated virus-mediated anti-calcitonin ribozyme therapy inhibits growth and metastasis of prostate cancer.”
“I talked about how gene therapy, based on blocking calcitonin synthesis, can lead to regression of aggressive prostate cancer,” he said.
“As a member of the organizing committee, I was involved in development of the meeting program, in addition to the selection of topics and speakers.”
Shah is the holder of the Mary E. and Darrell L. Calhoun Chair in Pharmacology.
He earned his Ph.D. from the University of Bombay, India. He received his post-doctoral training at the Karolinska Institute, Stockholm, Sweden and at the Max Planck Research Unit for Reproductive Medicine in Muenster, Germany.
He has served on review panels of federal funding agencies and on the editorial board of scientific journals.
He has authored over 80 original, peer-reviewed research articles, several book chapters and review articles, and mentored over 30 post-doctoral fellows, residents and graduate students.
His research is funded by the National Institutes of Health, and his current research interests include understanding the mechanisms associated with cancer metastasis, biomarkers for early detection of prostate cancer and development of experimental cancer therapeutics.